 follow-up bronchoalveolar lavag aid patient pneumocysti carinii pneumonia pneumocysti burden predict relaps analysi valu repeat bronchoalveolar lavag bal day patient risk earli relaps pneumocysti carinii pneumonia patient carinii pneumonia acquir immunodefici syndrom aid studi patient carinii methenamin silver stain bal fluid bal fluid modifi wright-giemsa techniqu wright-giemsa stain cell differenti count number carinii cluster nucleat cell estim carinii burden bal initi follow-up lavag patient patient clinic respons carinii therapi day nonrespond patient persist symptom respond patient respond respond relaps pneumonia month initi episod respond relaps diseas free follow-up period respond relaps carinii cluster case respond relaps carinii cluster count unchang respond group signific decreas percentag neutrophil bal neutrophil follow-up lavag nonrespond